Zobrazeno 1 - 10
of 41
pro vyhledávání: '"K. Burggraaf"'
Autor:
M. Ozdemir, T. van der Hulle, H. Van Poppel, K. Burggraaf, Marianne A. Jonker, C. Alvarez, Karine Goossens, H. Bloem, R. Pelger, Susanne Osanto, M. Wijffelman
Publikováno v:
Annals of Oncology. 30:v349
Background AR-inhibition with Enzalutamide may be an attractive alternative for 1L treatment of men with hormone-sensitive prostate cancer compared to androgen deprivation therapy (ADT). There is an unmet need for robust, reproducible imaging technol
Autor:
Adam F. Cohen, Margriet Ouwens, Marieke de Kam, Rik C. Schoemaker, Michiel J. B. Kemme, Hans Romijn, Martijn B A van Doorn, Ewoud J. van Hoogdalem, Richard Jones, K. Burggraaf
Publikováno v:
British Journal of Clinical Pharmacology. 62:391-402
Aims Thiazolidinediones (TZDs) not only enhance cellular glucose transport but are reported to have potent anti-inflammatory effects. These effects may play an important role in the insulin sensitizing mechanism, and possibly precede the effects on p
Autor:
Rik C. Schoemaker, Geert J. Lycklama à Nijeholt, Adam F. Cohen, K. Burggraaf, Leo J. Schultze Kool, Martin N. J. M. Wasser, Albert de Roos
Publikováno v:
Journal of Hepatology. 26:298-304
The aim was to study the reproducibility of magnetic resonance velocity mapping, when measuring portal vein and superior mesenteric artery blood flow, under fasting and post-prandial conditions. Magnetic resonance flow measurements for the portal vei
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
M. De Kam, S. van Os, G. Voortman, K. Burggraaf, I. De Visser, Joannes A. A. Reijers, L. Hooftman, E. de Cock, L. Wisman
Publikováno v:
Annals of Oncology. 23:ix103-ix104
Disclosure All authors have declared no conflicts of interest. FTMB is a biosimilar of trastuzumab (Herceptin®), a humanized monoclonal antibody targeting the human epidermal growth factor receptor 2 (HER2). Herceptin® is registered for treatment o
Autor:
Rik C. Schoemaker, W. A. Günzler, Horst Beier, Jean M. T. van Griensven, Kees Kluft, Linda G. M. Huisman, Joachim Gerloff, Ria Kroon, K. Burggraaf, Adam F. Cohen
Publikováno v:
Clinical pharmacology and therapeutics. 57(4)
Objective To investigate the influence of changes in liver blood flow on the pharmacokinetics and pharmacodynamics of single-chain unglycosylated urokinase-type plasminogen activator. Methods This open, randomized, crossover trial was carried out in
Autor:
G J, Blauw, R G, Westendorp, N, Srivastava, K, Burggraaf, M, Frölich, R, Simons, A F, Cohen, A E, Meinders
Publikováno v:
Journal of cardiovascular pharmacology. 26
The effect of hypoxia (SpO2 80%) on the arteriovenous production of endothelin-1 (ET) in the forearm was investigated in six healthy volunteers. In eight other subjects the local vascular effects of a low physiologic dose of intra-arterially administ
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
Journal of Clinical Oncology. 28:e13148-e13148
e13148 Background: The prognosis of testicular cancer (TC) patients is excellent. Curative chemotherapy leads to survival of men now at risk for chemotherapy-related long-term morbidity. Cisplatin-...
Publikováno v:
Annals of the New York Academy of Sciences. 667